Please use this identifier to cite or link to this item:
|Title:||pH dependent high transfection efficiency of mouse neuroblastomas using TransFectin|
|Source:||Chong, K.W.Y., Seet, S.J., Cheung, N.S., Lee, A.Y.-W., Koay, E.S.C. (2006). pH dependent high transfection efficiency of mouse neuroblastomas using TransFectin. Journal of Neuroscience Methods 158 (1) : 56-63. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jneumeth.2006.05.017|
|Abstract:||Mouse neuroblastoma cell lines are often used in lieu of mouse primary neurons in ex vivo experiments, as they provide an easier platform for transfection, compared to the latter. A well-known inherent problem with this strategy is the relatively low transfection efficiency (15-30%) of mouse neuroblastoma cell lines such as neuro-2A and N1E-115. We were able to improve the transfection efficiency of these cell lines by using the cationic lipid reagent, TransFectin™ (Bio-Rad, Hercules, CA, USA) to optimise the transfection conditions. Our results, based on fluorescence intensity determinations and Western blotting for enhanced green fluorescence protein (EGFP) over-expression in neuro-2A, demonstrated that pH is a crucial factor in determining the transfection efficiency. Under pH-optimised transfection conditions, flow cytometric analysis revealed high EGFP transfection efficiencies of 76.4 ± 0.5 and 60.9 ± 0.6% for neuro-2A and N1E-115, respectively. Notably, the optimised TransFectin™-based transfection system did not result in any detectable cytotoxicity to the mouse neuroblastomas. The resultant optimised system is economical, easy to use and does not require any specialised equipment. © 2006 Elsevier B.V. All rights reserved.|
|Source Title:||Journal of Neuroscience Methods|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 28, 2018
WEB OF SCIENCETM
checked on Feb 19, 2018
checked on Mar 12, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.